71 related articles for article (PubMed ID: 10548489)
1. Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells.
Fletcher TM; Trevino A; Woynarowski JM
Biochem Biophys Res Commun; 1999 Nov; 265(1):51-6. PubMed ID: 10548489
[TBL] [Abstract][Full Text] [Related]
2. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N
Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802
[TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
4. Detection of telomerase activity in Chinese hamster V79 cells and its inhibition by 7-deaza-deoxy guanosine triphosphate and (TTAGGG)4 in vitro.
Pandit B; Bhattacharyya NP
Biochem Biophys Res Commun; 1998 Oct; 251(2):620-4. PubMed ID: 9792823
[TBL] [Abstract][Full Text] [Related]
5. Effect of DNA secondary structure on human telomerase activity.
Fletcher TM; Sun D; Salazar M; Hurley LH
Biochemistry; 1998 Apr; 37(16):5536-41. PubMed ID: 9548937
[TBL] [Abstract][Full Text] [Related]
6. Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues.
Pai RB; Pai SB; Kukhanova M; Dutschman GE; Guo X; Cheng YC
Cancer Res; 1998 May; 58(9):1909-13. PubMed ID: 9581832
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo inhibition of telomerase activity from Chinese hamster V79 cells.
Pandit B; Bhattacharyya NP
Indian J Biochem Biophys; 2001; 38(1-2):42-7. PubMed ID: 11563329
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
9. Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates.
Fletcher TM; Salazar M; Chen SF
Biochemistry; 1996 Dec; 35(49):15611-7. PubMed ID: 8961922
[TBL] [Abstract][Full Text] [Related]
10. Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
Dominick PK; Keppler BR; Legassie JD; Moon IK; Jarstfer MB
Bioorg Med Chem Lett; 2004 Jul; 14(13):3467-71. PubMed ID: 15177454
[TBL] [Abstract][Full Text] [Related]
11. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.
Li H; Cao Y; Berndt MC; Funder JW; Liu JP
Oncogene; 1999 Nov; 18(48):6785-94. PubMed ID: 10597287
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
13. Real-time determination of telomerase activity in cell extracts using an optical biosensor.
Schmidt PM; Matthes E; Scheller FW; Bienert M; Lehmann C; Ehrlich A; Bier FF
Biol Chem; 2002 Oct; 383(10):1659-66. PubMed ID: 12452442
[TBL] [Abstract][Full Text] [Related]
14. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
16. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
[TBL] [Abstract][Full Text] [Related]
17. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
[TBL] [Abstract][Full Text] [Related]
18. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
[TBL] [Abstract][Full Text] [Related]
19. Determination of telomerase activity and telomere length.
Wu KD; Moore MA
Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.
Read M; Harrison RJ; Romagnoli B; Tanious FA; Gowan SH; Reszka AP; Wilson WD; Kelland LR; Neidle S
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4844-9. PubMed ID: 11309493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
